ICT&health October 24, 2025
A new clinical trial led by the Parkinson’s Wellness Innovation Center in Canada has shown that light therapy can significantly improve both motor and non-motor symptoms in people living with Parkinson’s disease, particularly when combined with exercise. The 72-week randomized controlled trial (RCT) was conducted using light therapy devices developed by the Australian MedTech company SYMBYX.
The study involved 59 participants with moderate Parkinson’s disease and compared two groups: one receiving active light therapy directed at the gut and brain (via a transcranial helmet), and another receiving a placebo treatment. Both groups participated in a structured exercise program.
Promising results
After 16 weeks, both groups showed improvements, likely due to a short-term placebo effect. However, during the third, open-label stage...
Today's Sponsors
Today's Sponsor